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Abstract: Current pharmacological therapies to treat neurological diseases are at best palliative and manage only the symptoms. 
Unfortunately, few therapies can affect diseases outcomes and alternative strategies such as stem cell therapy, neurotransplantation and deep 
brain stimulation are still in progress. Diseases such as Alzheimer’s and Parkinson’s disease become major public health challenge 
worldwide. In this way, the interest in the development of neuroprotective drugs of natural origin grows. Hence, this systematic review has 
quantified the studies that refer neuroprotective potential of plants listed in the Brazilian National List of Medicinal Plants of Interest to the 
Unified Health System (RENISUS). Searches were performed in two scientific databases (PubMed and Science Direct) from 2010 to 2016. 
A total of 4.532 articles met the inclusion criteria. 445 studies were considered eligible and were reviewed as full text. Following full 
analysis, 63 studies were included in this review. The studies covered 12 of the 71 plants belonging to RENISUS. In addition, two species 
are currently available in the Brazilian public health system as herbal medicine. This review may encourage and contribute to the proper use 
of medicinal plants in public health system. 
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Resumen: Las terapias farmacológicas actuales para tratar enfermedades neurológicas son, en el mejor de los casos, paliativas y sólo 
controlan los síntomas. Desafortunadamente, pocas terapias pueden afectar los avances de las enfermedades y las estrategias alternativas 
tales como terapia con células madre, neurotransplantate y la estimulación profunda del cerebro están todavía en curso. Enfermedades como 
el Alzheimer y la enfermedad de Parkinson se convierten en un reto importante para la salud pública en todo el mundo. De esta manera, 
crece el interés en el desarrollo de fármacos neuroprotectores de origen natural. Por lo tanto, esta revisión sistemática ha cuantificado los 
estudios que hacen referencia al potencial neuroprotector de las plantas incluidas en la Lista Nacional Brasileña de Plantas Medicinales de 
Interés para el Sistema Único de Salud (RENISUS). Las búsquedas se realizaron en dos bases de datos científicas (PubMed y Science 
Direct) de 2010 a 2016. Un total de 4,532 artículos cumplieron los criterios de inclusión. 445 estudios se consideraron elegibles y se 
revisaron como texto completo. Después del análisis completo, se incluyeron 63 estudios en esta revisión. Los estudios abarcaron 12 de las 
71 plantas pertenecientes a RENISUS. Además, actualmente hay dos especies disponibles en el sistema de salud pública brasileño como 
medicina herbaria. Esta revisión puede alentar y contribuir al uso adecuado de las plantas medicinales en el sistema de salud pública.  
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INTRODUCTION 
As human life expectancy has increased, also has 
increased the incidence of neurodegenerative diseases 
such as Alzheimer's and Parkinson's. These 
neurodegenerative pathologies comprise a large 
variety of disorders that result in the loss of 
functional neurons and synapses (Solanki et al., 
2016). Unfortunately, neurological disorders are 
becoming major public health challenge worldwide 
and major cause of death (Rios et al., 2016).  
The use of vegetal extracts and 
phytochemicals for medicinal purposes such as 
prevention, treatment and cure of disorders is one of 
the oldest practices of traditional folk medicine (Lin, 
2011; Huppert et al., 2016). Despite the increased use 
of synthetic drugs in recent years, about 80% of the 
population in developing countries depend on 
medicinal plants as the only access to basic health 
care (Mendis et al., 2007; Cordell & Colvard, 2012). 
Increasing evidences suggest that natural products are 
able to attenuate neurotoxicity. In addition, plant 
extracts may have a complementary or alternative 
role in preventing and/or treating neurodegenerative 
diseases (Lin, 2011; Pandareesh et al., 2015). In view 
of that, the Brazilian public health system provides 
plant-derived phytomedicines to the population since 
2007. In 2009, Brazil’s Ministry of Health published 
the National List of Medicinal Plants of Interest to 
the Unified Health System (RENISUS) with the aim 
to encourage the use of complementary therapies in 
the Unified Health System (SUS), as well as to 
promote research on medicinal plants and to establish 
the correct and safe use of the same. It was prioritized 
the inclusion of native species of various biomes of 
the country. The plants were preselected by regions 
that alluded to its folk use. In addition, it was 
included plants whose effects have been scientifically 
proven. Currently, SUS offers the use of 12 herbal 
medicines (aloe, artichoke, cascara, cat’s claw, devil's 
claw, espinheira-santa, guaco, mastic, mint, plantago, 
soy isoflavone and willow) derived from plants that 
belong to RENISUS (Marmitt et al., 2016). 
Therefore, the aim of the present systematic review 
was to quantify the scientific reports on RENISUS 
plants with neuroprotective potential. 
 
METHODS 
Search strategy  
We conducted a search in PubMed and ScienceDirect 
databases in an attempt to cover all studies 
investigated medicinal plants of RENISUS list that 
demonstrated neuroprotective potential. In this sense, 
we analyzed papers published since the creation of 
RENISUS in the period between January 2010 and 
December 2016. The keywords used to search were 
the scientific names of medicinal plants as described 
in RENISUS list.  
 
Inclusion and exclusion criteria  
In order to be considered in this analysis, articles had 
to meet the following two inclusion criteria: the 
neuroprotective potential of the medicinal plant; and 
evidence in preclinical or clinical phase. All scientific 
papers available as full and open access texts were 
considered, regardless of the language. Reviews, 
semi-structured interviews and research articles that 
addressed the chemical constituents of the plants 
without the intention to demonstrate neuroprotective 
potential were excluded. In addition, papers that only 
mentioned the empirical use of plants were also 
excluded.  
 
Study selection 
Two reviewers independently reviewed the retrieved 
articles and the analysis of these studies was 
performed in three steps. The primary search 
comprised the screening of titles and selecting those 
with terms related to neuroprotective potential. After 
reading the abstract of the previous chosen reports, 
irrelevant or duplicated papers were excluded. The 
final search consisted of full reading and qualitative 
analysis of the selected papers in order to elect those 
that mentioned some evidence of neuroprotective 
potential. 
 
RESULTS 
The database search retrieved 4.532 records. Out of a 
total of 1.289 pre-selected papers, 844 articles that 
did not meet the inclusion criteria were excluded and 
the remaining 445 articles were assessed for 
eligibility. Afterwards, 63 full text articles (1,39% of 
all searched papers) were considered suitable for this 
review. All selected reports were written in English 
and involved in vitro (21 studies), in vivo treatments 
(41 articles) and preclinical in humans (three 
research). Figure Nº 1 depicts an overview of the 
study selection procedure. The therapeutic effects 
attributed to the plants were analyzed according to 
Table Nº 1.  
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Figure Nº 1 
Flowchart of the search strategy and study selection 
 
 
Table Nº 1 
Details on each study regarding methodological and outcome aspects of selected researches 
 
Plant / family Compound / plant part 
and concentration 
Main results Reference / 
country 
Allium sativum L. 
(Amaryllidaceae) 
Orally administered diallyl 
trisulfide (DATS) at 80 
mg/kg body weight/day 
DATS showed multifunctional neuroprotective effects in 
transgenic mice with amyotrophic lateral sclerosis (SOD1-
G93A). Oral administration of the compound at the start of 
the clinical phase delayed the onset time of the disease. 
Treatment with the compound reduced the expression of 
the glial fibrillic acid protein (GFAP) and induced heme 
oxygenase-1 (HO-1) in the lumbar spinal cord of rats 
Guo et al., 2011 
China 
Allium sativum L. 
(Amaryllidaceae) 
Pretreated with S-
Allylcysteine (SAC) (125 
mg/kg intraperitoneal 
(i.p) daily for 17 days 
SAC induced neuroprotective effect against oxidative stress 
induced by 1-Methyl-4-phenylpyridinium (MPP (+) model 
used to evaluate neuroprotective agents for Parkinson's 
disease) in the striatum of mice. In animals treated with 
SAC there was attenuation of MPP(+)-induced loss of 
striatal dopamine (DA) levels. The neuroprotective effect 
was associated with blockade of lipid peroxidation and 
reduction of superoxide radical production (positive 
regulation of Cu-Zn-superoxide dismutase activity). 
Behavioral analyses showed that SAC improved MPP(+)-
induced impairment of locomotion 
Rojas et al., 2011  
Mexico 
Allium sativum L. 
(Amaryllidaceae) 
Allicin (1, 10 and 50 
mg/kg) by i.p injection 
per day, respectively for 2 
Allicin significantly reduced the volume of the spinal cord 
infarctions, improved the histopathologic features and 
increased the number of motor neurons in a dose-
Zhu et al., 2012 
China 
Screening by title and 
abstract  
(n = 1.289 articles) 
Eligibility  
(n = 445 articles) 
Selected  
(n = 63 articles) 
PubMed: n = 905 
Science Direct: n = 384 
PubMed: n = 298 
Science Direct: n = 147 
PubMed: n = 33 
Science Direct: n = 2 
Both: n = 28 
Primary search – 
identification 
(n = 4.532 articles) 
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Science Direct: n = 1241 
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weeks dependent manner. Allicin also significantly suppressed the 
accumulations of protein and lipid peroxidation products, 
and increased the activities of endogenous antioxidant 
enzymes, including catalase (CAT), superoxide dismutase 
(SOD), glutathione peroxidase (GPX) and glutathione S-
transferase (GST). Allicin exerts neuroprotection against 
spinal cord I/R injury in rabbits, which may be associated 
with the improvement of mitochondrial function. 
Allium sativum L. 
(Amaryllidaceae) 
Garlic intake of the study 
population (2.9 g/day) in 
125 Chinese patients with 
prior ischemic stroke (ISS) 
Daily consumption of garlic protects endothelial function in 
patients with ischemic stroke and may play a role in the 
secondary prevention of atherosclerotic events through 
brachial artery flow-mediated dilatation (FMD). The daily 
ingestion of garlic correlated significantly with FMD 
Lau et al., 2013 
China 
Allium sativum L. 
(Amaryllidaceae) 
Diallyl trisulfide (DATS) 
(10 μg/kg - 10 mg/kg) 
DATS induced increase in p21Waf1 expression (cyclin-
dependent p21 kinase inhibitor), which correlated with 
increased p53 expression and degradation of the MDM2 
protein (p53 negative regulator). Compound reduced the 
tumor mass and the number of mitotic cells in the tumors. 
It decreased the activity of histone deacetylase (HDAC), 
pro-tumor markers (survivin, Bcl-2, c-Myc, mTOR, EGFR, 
VEGF), promoting apoptotic factors (Bax, mcalpian, 
caspase-3) in mice. DATS may be an effective therapeutic 
agent in preventing tumor progression and inducing 
apoptosis in human GBM in vivo without compromising 
liver function 
Wallace et al., 
2013 
USA 
Allium sativum L. 
(Amaryllidaceae) 
Animals were i.p treated 
with 50 mg/kg allicin and 
in vitro in culture of 
cortical neurons (50 μM) 
The with allicin treatment in a model of mean occlusion of 
the cerebral artery of rats reduced the volume of the 
cerebral infarct, attenuated cerebral edema and decreased 
levels of neurological deficits. Allicin increased neuronal 
viability, decreased lactate dehydrogenase (LDH) release, 
and inhibited apoptotic neuronal death following oxygen 
deprivation. There was increased expression of 
sphingosine kinase 2 (Sphk2) both in vivo and in vitro 
Lin et al., 2015 
China 
Allium sativum L. 
(Amaryllidaceae) 
Allicin (50 mg/kg i.p.) was 
administered 3 h after 
daily reperfusion in rats 
for five consecutive days 
Allicin protects the brain from cerebral I/R injury induced 
by occlusion of middle cerebral artery occlusion (MCAO), 
which can be attributed to its anti-apoptotic and anti-
inflammatory effects. Allicin reduced cerebral infarction 
area, brain water content, neuronal apoptosis, tumor 
necrosis factor-α (TNF-α) levels and myeloperoxidase 
(MPO) activity in the serum 
Zhang et al., 2015 
China 
Allium sativum L. 
(Amaryllidaceae) 
Ethanol extract (0.5 or 1.0 
%) and S-allylcysteine 
(SAC) (5 or 10 mM) 
Extract and SAC, decreased cobalt chloride (CoCl2) -induced 
hypoxia in PC-12 cells, derived from a pheochromocytoma 
of the rat adrenal medulla, a useful model for the study of 
nerve cell differentiation. Treatment with extract and SAC 
decreased reactive oxygen species (ROS) levels and the 
amount of cells in the early and late phases of apoptosis, 
this protective effect was associated with attenuation in 
stabilization of the subunit of the hypoxia-inducible factor 
Orozco-Ibarra et 
al., 2016 
Mexico 
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(HIF-1α) 
Calendula 
officinalis L. 
(Asteraceae) 
Compounds 28-O-β-D-
glucopyranosyl-oleanolic 
acid 3-O-β-D–
glucopyranosyl (1→3)-β-
D-glucopyranosiduronic 
acid (CS1) and oleanolic 
acid 3-O-β-D–
glucopyranosyl (1→3)-β-
D-glucopyranosiduronic 
acid (CS2) extracted from 
the butanol fraction of 
the seeds and tested in 
concentration (2.5, 5 and 
10 μg/mL) 
Compounds CS1 and CS2 exerted protection in mouse 
melanoma cells (B16), rat neuroblastoma (neuro-2A) line, 
against hydrogen peroxide (H2O2) induced toxicity. CS2 
exhibited melanin biosynthesis stimulatory activity. CS1 
showed a stimulatory effect for the production of 
hyaluronic acid in human dermal fibroblasts (NHDF-Ad). 
Both compounds did not show any inhibitory effect on 
both lipase and adipocyte differentiation. Compound CS2 
can protect neuro-2A cells and increase cell viability 
against H2O2 
Zaki et al., 2016 
Egypt, Japan and 
USA 
Curcuma longa L. 
(Zingiberaceae) 
A combination 
of candesartan 50 mg i.p 
and curcumin 60 mg/kg 
i.p 
10 days before MCAO in 
mice 
Curcumin combined with candersartan increases 
synergistically the inhibitory action of candesartan on 
cerebral ischemia in rats by suppressing changes in blood 
flow and oxidative stress via antioxidant properties, 
suggesting beneficial and preventive effects in ischemic 
brain damage. The treatment restored levels of SOD and 
glutathione-S-transferase (GST), thiobarbituric acid and 
heart rate 
Awad, 2011 
Egypt 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (5, 10, 15, 20 
and 25 μM) for 24 h 
Curcumin activates nuclear factor erythroid 2-related 
factor 2 (Nrf2) target genes in primary spinal cord 
astrocytes, decreases the level of intracellular ROS, and 
attenuates oxidative damage and mitochondrial 
dysfunction in vitro, which may serve as a therapeutic 
strategy for neurodegenerative diseases 
Jiang et al., 2011 
China 
Curcuma longa L. 
(Zingiberaceae) 
Pretreated with curcumin 
(80 mg/kg body weight 
orally, in 1% w/v sodium 
carboxy methyl cellulose 
and 1% tween 80 in 
phosphate buffer saline) 
once daily for 3 weeks 
followed by a single 
injection of 6-OHDA in 
the striatum on the 22nd 
day 
Parkinsonian model in rats induced by 6-hydroxydopamine 
(6-OHDA) (10 μg/2 μl in 0.1% ascorbic acid–saline) the 
behavioral activities were significantly preserved with 
curcumin pre-treatment (80 mg/kg for 21 days), 
attenuating levels of LPx, glutathione (GSH), GPX, 
glutathione reductase (GR), SOD, catalase (CAT) and 
tyrosine hydroxylase (TH). Curcumin is useful in preventing 
and has therapeutic potential in attenuation the 
Parkinson's disease 
Khuwaja et al., 
2011 
India 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (60 mg / kg) 
suspension orally (0.5% 
(w/v) sodium 
carboxymethylcellulose) 
daily for 14 days 
Treatment with curcumin exerted a neuroprotective effect 
in the prevention of cortical dysfunction associated with 
diabetes in mice. The antioxidant potential of curcumin 
attenuated cholinergic dysfunction and oxidative stress 
and improved glucose transport and still delayed the 
associated diabetic complications. Treatment induced 
decreased gene expression of muscarinic M1, insulin 
receptor, SOD, choline acetyl transferase and increased 
Peeyush Kumar et 
al., 2011 
India 
Marmitt et al.  Medicinal plants with neuroprotective potential 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/89 
 
gene expression of muscarinic M3, α7-nicotinic 
acetylcholine receptor, acetylcholine esterase and glucose 
transporter 3 (GLUT3) in cerebral cortex of diabetic rats 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (300 mg/kg, 
p.o.) dissolved in DMSO 
(50%) was administered 
orally by gavage at 
volumes not greater than 
1.0 ml/100 g body weight 
Co-administration of curcumin with four antiepileptic 
drugs (sodium valproate, phenytoin, phenobarbital and 
carbamazepine), acted as adjuvant in the epileptic seizure 
induced by pentylenetetrazol (PTZ) or induced by 
electroshock in mice. Co-administration increased 
effectiveness of treatments and reduced side effects. Co-
administration of curcumin with sub-therapeutic dose of 
valproate significantly increased the latency to myoclonic 
jerks 
Reeta et al., 2011 
India 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (IC50=24.9 µM) Diet containing curcumin and co-treatment with cisplatin 
or doxorubicin increased cytotoxicity and apoptosis was 
observed in human neuroblastoma cells, SK-N-AS and SK-
N-BE. Apoptosis was associated with decreased the nuclear 
factor-κB (NF-κB) activity and a reduction in the expression 
of Bcl-2 and Bcl-xL 
Sukumari-Ramesh 
et al., 2011 
USA 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin pretreatment 
intragastric (200 mg/kg) 
twice a day for 
24 days 
Curcumin pretreatment in rats the DA content 
reestablished in the striatum and the number of TH-
immunoreactive neurons decreased after 6-OHDA 
treatment. The preventive and protective effects of 
curcumin against 6-OHDA may be attributable to the 
ironchelating activity of curcumin to suppress the iron-
induced degeneration of nigral dopaminergic neurons 
Du et al., 2012 
China 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (20 μM) Combination of 20 µM curcumin and 10 nM paclitaxel 
(PTX) worked synergistically therapeutic action in human 
brain tumor stem cells (HBTSC) and human glioblastoma 
LN18 (p53 mutant and PTEN proficient) and U138MG (p53 
mutant and PTEN mutant) cells, through induction of 
apoptosis, phosphorylation of Bcl-2 protein, cleavage of 
Bid to tBid, increase of Bax levels, mitochondrial release of 
cytochrome c, and apoptosis induction factor (AIF). 
Combination therapy inhibited cell proliferation, reduced 
the expression of survival factors and also angiogenic 
factors 
Hossain et al., 
2012 
USA 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (12.5, 2 and 50 
mg/kg body weight) 
administred out once a 
day, 5 days each week, 
for 30 days 
Exposure to cigarette smoke generated changes in the 
activity of acetylcholinesterase (AChE), influencing the loss 
of memory. Treatment with curcumin has been involved in 
the modulation of cholinergic neurotransmission, 
improved cognitive deficits induced by smoke, exerted a 
protective effect on learning and memory and decreases 
cholinergic alterations in rats exposed to smoke 
Jaques et al., 
2012 
Brazil 
Curcuma longa L. 
(Zingiberaceae) 
Oral administration of 
curcumin (30 mg/kg body 
weight) in drinking water 
Supplementation of curcumin with 6-propyl-2-thiouracil 
(PTU) of 0,05% in rats for 30 days showed a significant 
reduction in the level of lipid peroxidation (LPx) in brain. 
The curcumin modulates the expression of superoxide 
dismutase in rat brain cortex and cerebellum under PTU-
Jena et al., 2012a 
India 
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induced hypothyroidism 
Curcuma longa L. 
(Zingiberaceae) 
Oral administration of 
curcumin (30 mg/kg body 
weight) in drinking water 
The decreased activity of superoxide dismutase (SOD) and 
protein expression of SOD1 in cerebellum of T4-treated 
rats were ameliorated after pretreatment administration 
of curcumin, which also induced a decrease in LPx levels. 
The regulation of expression of SOD by curcumin in 
different regions (cerebral cortex and cerebellum) of rat 
brain is different under hyperthyroidism 
Jena et al., 2012b 
India 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (50 mg/kg) was 
injected during 10 days 
(i.p.) 
Curcumin exhibited neuroprotective effect against toxicity 
exerted by the intracerebroventricular administration of 
homocysteine, and consequently improved locomotor 
function in animals and preventing the onset of Parkinson's 
disease 
Mansouri et al., 
2012 
Iran 
Curcuma longa L. 
(Zingiberaceae) 
Bisabolene 
sesquiterpenoids 
extracted of dried 
rhizome powder 
Bisabolene sesquiterpenoids exhibited anticonvulsant 
activities in a PTZ -induced seizure assay in larval zebrafish 
and rats showing possible neuromodulatory activity 
Orellana-Paucar 
et al., 2012 
Belgium 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (20 μmol/L) Curcumin protects against staurosporine (STS)-induced 
cytotoxicity in rat hippocampal neurons in primary culture 
assay in vitro. Caspase-3, heat shock protein 70, Akt and 
reactive oxygen species (ROS) activation may be involved 
in this protection 
Qin et al., 2012 
China 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin C3 Complex® 
per day in two divided 
doses for 24 weeks (2 gm 
or 4 gm) 
Oral administration of C3 Complex® was associated with 
reduction of hematocrit and increase of glucose levels in a 
group of 36 patients with Alzheimer's disease, with good 
tolerance and limited bioavailability to compound 
Ringman et al., 
2012 
USA 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (100 mg/kg, 
orally) daily for 28 days 
Curcumin protected against biochemical changes and 
oxidative damage induced by cypermethrin (CYP) in rats. 
Curcumin treatment decreased levels of biochemical 
markers and lipid peroxidation in the blood and increased 
levels of GSH, CAT and GPX, preserving the normal 
histological architecture of the liver, kidney and brain 
Sankar et al., 
2012 
India 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (30 and 60 
mg/kg; oral gavage) 
Treatment with curcumin showed protective effect and 
reversed cognitive déficits associated with increased AChE 
activity, neuroinflammation (oxidative-nitrosative stress, 
TNF-α, interleukins-1β (IL-1β) and TGF-β1) and neuronal 
apoptosis (NF-κB and caspase 3) in the cerebral cortex and 
hippocampus of mice pups postnatally exposed to etanol 
Tiwari y Chopra, 
2012 
India 
Curcuma longa L. 
(Zingiberaceae) 
Tetrahydrocurcumin 
(THC) (25mg/kg/day 0.1% 
DMSO dose) was given 
for 3 days by i.p injection 
in mice after 30 min of 
ischemia induction 
THC decreased oxidative damage and ameliorated the 
homocysteinylation of cyto-c in-part by metalloproteinase-
9 (MMP-9) activation which leads to autophagy in I/R 
groups as compared to sham operated groups. This study 
suggests a potential therapeutic role of dietary THC in 
cerebral ischemia. The size of edema and cerebral 
infarction was reduced in animals treated with THC 
Tyagi et al., 2012 
USA 
Curcuma longa L. 
(Zingiberaceae) 
Ten days after glioma 
implantation (C6), 
animals were trated with 
Curcumin is a potential agent against the human (U138MG, 
U87 and U373) malignant glioblastomas (GBM) cell lines 
and glioma implantation (C6) in rat. In vitro, curcumin 
Zanotto-Filho et 
al., 2012 
Brazil 
Marmitt et al.  Medicinal plants with neuroprotective potential 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/91 
 
(50 mg/kg/day curcumin 
solubilized in sterile 
DMSO) were 
administered 
intraperitoneal (i.p) for 10 
days 
inhibited proliferation, migration and induced cell death in 
GBM growth models. In U138MG, curcumin decreased the 
constitutive activation of PI3K/Akt and the NF-κB pathway, 
inducing mitochondrial dysfunction as a prelude to 
apoptosis. In mice implanted with C6, curcumin decreased 
the volume of brain tumors by 81.8%. No tissue evidence 
of metabolic transaminases (creatinine and alkaline 
phosphatase) (cholesterol and glucose), oxidative damage 
or toxicity was observed 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (50, 100, or 
200 mg/kg) i.p. injection 
Curcumin exhibited antidepressant effect through 
neurotrophic activity and increased brain-derived 
neurotrophic factor (BDNF) (antidepressant) in rat 
hippocampus. There was a dose-dependent reduction of 
immobility in the forced swim test (FST) 
Hurley et al., 
2013 
USA 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (1 μM) Curcumin selectively inhibited L-type Ca2+ channels in cell 
cultures of rat hippocampal neurons. Reversibly inhibited 
high voltage-gated Ca2+ channel (HVGCC) currents (IBa) 
induced by the intracellular application of the PKC-θ 
peptide inhibitor or by the PKC-θ knockdown siRNA in rat 
hippocampal neurons. In these neurons, new PKC isoforms 
including PKC-δ, PKC-ɛ and PKC-θ were endogenously 
expressed. Compound inhibited the PKC-θ dependent 
IBavia pathway, which could contribute to its 
neuroprotective effects on rat hippocampal neurons 
Liu et al., 2013 
China 
Curcuma longa L. 
(Zingiberaceae) 
Combination extract of 
four plants traditional 
chinese medicine, 
including rhizoma C. 
longa at concentrations 
(0.075 g/kg-1 x day-1, 
0.15 g/kg-1 x day-1, 0.30 
g/kg-1 x day-1) for 4 or 8 
months 
The combination of extracts containing C. longa rhizomes 
showed a neuroprotective mechanism in the prediction of 
Alzheimer's disease through inhibition of protein 
expression and also in immunohistochemical analysis of 
the 3β glycogen synthase-kinase (A-GSK-3β) target in the 
cerebral cortex of transgenic mice (APPV7171) 
Shi et al., 2013 
China 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (2,5 μM and 5 
μM) for 24 e 48 h 
Neprilysin (NEP) is a poorly expressed metallopeptidase in 
the brain. Treatment with curcumin induced NEP gene 
restoration by demethylation of the CpG dinucleotide, 
concomitant with Akt inhibition, NF-κB suppression, and 
proinflammatory cytokines, cyclooxygenase 2 (COX-2), 
inducible nitric oxide synthase (iNOS) in rat neuroblastoma 
cells (N2a), which suggests potential for treatment of 
Alzheimer's disease 
Deng et al., 2014 
China 
Curcuma longa L. 
(Zingiberaceae) 
Compound (ar-) 
turmerone at serial 
concentrations of 1.56 to 
25 μg/mL 
Compound induced proliferation of neural stem cells (NSC) 
from fetal rats. In vitro and in vivo, turmerone promoted 
the neuronal differentiation of NSC. In vivo, after 
intracerebroventricular (i.c.v.) injection of the compound, 
there was greater proliferation of NSC from the 
subventricular zone (SVZ) and hippocampus of adult rats. It 
is suggested (Ar-) turmerone as a promising candidate in 
the regeneration of neurological disease 
Hucklenbroich et 
al., 2014 
Germany 
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Curcuma longa L. 
(Zingiberaceae) 
Curcuminóides 
diarylalkyls curcumin 
(CCN), 
demethoxycurcumin 
(DMCCN) and 
bisdemetoxicurcumina 
(BDMCCN) extracted 
from rhizomes and tested 
at concentrations (200, 
500, and 1000 μM) 
The human β-amyloid enzyme (BACE-1) is a key enzyme 
responsible for the production of amyloid plaques, which 
implies the progress and symptoms of Alzheimer's diseas. 
Curcuminoids CCN, DMCCN and BDMCCN inhibited the 
activity of BACE-1 in the Drosophila model. Structural 
features, such as degrees of saturation, functional group 
and hydrophobicity, appear to be involved in the inhibitory 
action of curcuminoids against BACE-1 
Wang et al., 2014 
Republic of Korea 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin (10 μM) Curcumin improved microglial viability against amyloid β 
(Aβ42) and suppressed the expression of Aβ42-induced 
CD68 glycoprotein. It decreased the levels of IL-1β and 
interleukin-6 (IL-6) and TNF-α induced by Aβ42. It exerted 
an inhibitory effect on the phosphorylation of the ERK1/2 
MAPK and p38 MAPK pathways induced by Aβ42 in the 
microglia, thus attenuating the inflammatory responses of 
the cerebral microglia 
Shi et al., 2015 
China 
Curcuma longa L. 
(Zingiberaceae) 
Pretreatment with 
curcumin (2,5–20 
μmol/L) for 24 h 
Curcumin supressed induced apoptosis through the 
overexpression of appoptosin in cells of dopaminergic 
neurons SH-SY5Y (human neuroblastoma). It induced a 
positive regulation of HO-1 expression, reducing the 
production of intracellular heme and ROS, preventing loss 
of mitochondrial membrane potential (ΔΨm) 
Zheng et al., 2015 
China 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin intragastrically 
administered (100 mg/kg) 
twice a day for 50 days 
Curcumin attenuated oxidative damage such as rotenone-
induced dopaminergic neuronal loss in the central nervous 
system (SNpc) of rats through the activation of the Akt / 
Nrf2 signaling pathway. Curcumin relieved motor 
dysfunction, increased GSH levels, and reduced ROS 
activity and malondialdehyde (MDA) content. Increase 
suppressed tyrosine hydroxylase (TH) activity in the SNpc 
of rotenone (ROT)‑injured rats. Treatment with the 
compound restored levels of HO-1 and expression of 
NADPH 
Cui et al., 2016 
China 
Curcuma longa L. 
(Zingiberaceae) 
Ethanolic extract KCHO-1 is a product composed of 30% of ethanolic extracts 
obtained from the leaves of nine plants, including C. Longa. 
Preparation showed direct neuroprotective effects on 
mouse hippocampal cells (HT22). KCHO-1 suppressed 
levels of cellular damage and generation of ROS induced by 
glutamate and H2O2. KCHO-1 increased the mRNA and 
protein expression levels of HO-1, induced the extracellular 
activation of ERK and increased nuclear translocation of 
Nrf2 
Lee et al., 2016 
Republic of Korea 
Curcuma longa L. 
(Zingiberaceae) 
Curcumin at a dose of 200 
mg/kg/day or 300 
mg/kg/day via gavage for 
2 weeks 
Compound protects neuronal cells against status 
epilepticus-induced hippocampal neuronal damage in the 
lithium-pilocarpine-induced status epilepticus in rat model 
through induction of autophagy and inhibition of 
necroptosis. Results have demonstrated an alteration in 
expression of Beclin-1 and Microtubule-associated protein 
Wang et al., 2016 
China 
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1A/1B-light chain 3 (LC3) proteins for autophagy and mixed 
lineage kinase domain-like (MLKL) protein and protein 
kinase-1 (RIP-1) for necroptosis in almost all four regions 
(CA1, CA3, DG, and H) of rat hippocampus 
Glycine max (L.) 
Merr. (Fabaceae) 
Compound soyasaponin I 
(5, 10, and 20 mg·kg-1) 
was administered orally 
once a day for 4 weeks 
Oral administration of soyasaponin I exhibited significant 
memory-enhancing effects in the passive avoidance, Y-
maze, and Morris water maze tests in rats. Oral 
administration of soyasaponin I increased the amount of 
neural precursor cells (NPCs), cell proliferation markers (Ki-
67), and neuronal differentiation (NeuN, TUJ1, and MAP2). 
The compound also increased neurite prolongation and the 
number of neurites during the differentiation of NPCs. 
Soyasaponin I can enhance learning and protect memory 
impairment by promoting the proliferation and 
differentiation of NPCs in the hippocampus by facilitating 
neuronal regeneration and minimizing neuroinflammation 
Hong et al., 2013 
Republic of Korea 
Matricaria 
chamomilla L. 
(Asteraceae) 
Hydroalcoholic extract 
leaves (25 mg·kg-1, i.p.) 
Administration of extract before formalin injection showed 
decrease of pain responses in both phases of formalin test 
and showed has anti inflammatory effects in the second 
phase of formalin. Injection of extract and cisplatin 
together have shown that extract is able to decrease the 
second phase of cisplatin-induced pain. Extract have 
analgesic and painful neuropathic effects, is able to 
decrease cisplatin-induced pain and inflammation better 
than morphine. 
Abad et al., 2011 
Iran 
Matricaria 
chamomilla L. 
(Asteraceae) 
Compound Apigetrin 
(12.5, 25, 50, or 100 μM) 
for 24 h 
Compound reduced mRNA expression and secretion of 
inflammatory cytokines, TNF-α and IL-6, prostaglandin E2 
(PGE2) level, suppressed expression of NF-kB, all 
stimulated by lipopolysaccharide (LPS), besides nitric oxide 
(NO) production, as well as expression of COX-2 and iNOS 
in BV-2 mouse micróglia. Apigetrin enhanced expression of 
antioxidant enzymes, HO-1 and Nrf2 in BV-2 cells. 
Compound also increased 2,20-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity, indicating antioxidative activity. Finaly, 
apigetrin inhibited H2O2-induced cell death in HT22 
hippocampal cells 
Lim et al., 2016 
Republic of Korea 
Mentha piperita 
L. (Lamiaceae) 
Aqueous extract from 
leaves was administered 
to rats by oral gavages at 
a dose of 1 g/kg body 
weight/day for seven 
consecutive days 
Extract activity reduced gamma radiation-induced 
neuronal injury in rats. The biochemical analysis registered 
a decrease in GR and SOD levels after treatment with 
extract. Several histopathological changes were detected 
in rat brain tissues, such as pyrolysis signals in pyramidal 
cells of the cortex, nuclear vacuolization, apoptosis and 
neural degeneration. In the rats irradiated with gamma 
rays pretreated with the extract, there was an 
improvement in all the parameters tested above by means 
of a state of homeostasis and stabilization of the DNA cycle 
with a clear improvement in the analysis of the cell cycle 
Hassan et al., 
2013 
Egypt 
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and in the defense system antioxidant 
Mikania laevigata 
Sch.Bip. ex Baker 
(Asteraceae) 
Ethanolic extract leaves 
(40 μl/mL) 
Pretreatment of extract for 30 min before incubation with 
Philodryas olfersii venom (50 μg/mL) completely protected 
mouse phrenic nerve-diaphragm (PND) from 
neuromuscular blockade and delayed the blockade in chick 
biventer cervicis (BC). Pretreatment of the preparations 
with extract protected against venom-induced muscle 
damage by 80.3% and 60.4% in PND and BC, respectively, 
and prevented TNF-α and interferon gamma (IFNγ) 
expression. The extract protected nerve-muscle 
preparations against the myotoxic, neurotoxic and 
inflammatory effects of P. olfersii venom 
Collaço et al., 
2012 
Brazil 
Momordica 
charantia L. 
(Cucurbitaceae) 
Lyophilized fruit juice 
(6.5 g powder/100 g of 
fresh juice). The powder 
so obtained was oral 
administrated in diabetic 
mice (200-800 mg/kg, 
p.o., o.d.) 
The cerebral oxidative stress and damage, and neurological 
deficits were dose dependently attenuated. Moreover, 
pre-treatment with the lyophilized juice also exhibited 
dose dependent antihyperglycemic activity in diabetic mice 
Malik et al., 2011 
India 
Passiflora 
incarnata L., 
(Passifloraceae) 
Formulations of ethanolic 
extract from leaves (fresh 
leaves: 65% EtOH and 
aqueous, dried leaves: 
65% EtOH at 4° C, EtOH 
65% at 100° C and 
aqueous) continuous 
administration in the 
drinking water (1000 mg 
freeze dried 
extract/kg/day; equivalent 
to between 4.2 and 13 g 
of dry herb/kg/day 
depending on preparation 
method) for one week 
Whole Passiflora extract induced prominent, dose-
dependent direct GABAA receptor currents in hippocampal 
slices. Aqueous extracts of fresh leaves and dried leaves 
65% EtOH at 4° C exhibited anticonvulsant effects against 
pentylenetetrazole (PTZ) -induced convulsions in CF-1 
mice. Anxiogenic effects in the elevated plus maze were 
seen in mice receiving any of the five Passiflora extracts in 
vitro assays 
Elsas et al., 2010 
USA 
Passiflora 
incarnata L., 
(Passifloraceae) 
Hydroethanolic extract 
leaves (150, 300, and 600 
mg/kg; i.p.) 
Extract suppressed PTZ-induced seizures and improved 
post-ictal depression associated. The treatment reduced 
the severity of epileptic seizures in a dose-dependent 
manner and also attenuated serotonin and noradrenaline 
levels in the brain, With better action than the antiepileptic 
drug diazepam 
Singh et al., 2012 
India 
Passiflora 
incarnata L., 
(Passifloraceae) 
Ethanol extract from 
leaves (30, 100 and 300 
mg/kg body weight (bw)) 
for 7 weeks 
Oral extract administration reduced memory anxiety rates 
in rats. Extract administration influenced the reduction of 
the content of glutamic acid and cortical serotonin in the 
hippocampus. The results partially confirmed the proposed 
mechanism of action of P. incarnata involving GABA 
receptors, which is the main inhibitory neurotransmitter in 
the brain 
Jawna-Zboińska 
et al., 2016 
Poland 
Punica granatum 
L. (Lythraceae) 
Pomegranate peel 
methanolic extract (200 
mg/kg bwt) 
Extract attenuated neurotoxicity by decreasing aluminum 
chloride-induced oxidative stress in in brain of female rats, 
and these effects may be related to the stimulation of anti-
Abdel Moneim, 
2012 
Spain 
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apoptotic protein (Bcl-2) and antioxidant activities 
Punica granatum 
L. (Lythraceae) 
P. granatum peel 
methanolic extract (75 
and 150 mg of kg body 
weight) administred for 
45 days 
Administration of the extract decreased the oxidative 
stress in the brain of diabetic mice induced by aloxane, 
regulating the antioxidant defense mechanism, attenuating 
the lipid and protein oxidation. Supplementation with the 
extract showed increased SOD and GPX activity and 
decreased MDA, with the most evident changes in the 
hippocampus region 
Middha et al., 
2012 
India 
Punica granatum 
L. (Lythraceae) 
Extract of fruits from 
pomegranate (225 mg/kg) 
for seven days once a day 
through orogastric gavage 
Extract treatment exhibited neuroprotective effects in rats 
by attenuating oxidative stress and inflammatory response 
in the sciatic nerve, increasing total antioxidant capacity 
and decreasing levels of TNF-α, IL-1β and MDA 
Celik et al., 2013 
Turkey 
Punica granatum 
L. (Lythraceae) 
Fruit Seeds Essential Oil 
(2,0 mg/mL) 
Neuroprotective effect of the essential oil reversed 
cytotoxicity in neuronal cells (PC12) induced by 3-
nitropropionic acid- (3-NP), which may be due to the ability 
of the oil to neutralize ROS, NO, LPx and LDH generated by 
neurotoxicity Induced by 3-NP (100 mM), increasing levels 
of antioxidant enzymes 
Al-Sabahi et al., 
2014 
India 
Punica granatum 
L. (Lythraceae) 
Pomegranate seed oil 
(PSO) was unlimitedly 
administered; and ater-
soluble nanoemulsions 
from PSO (Nano-PSO) 
administered either by 
gavage 5 times a week 
(150 μl/day), 
Nano-PSO delayed the development of Alzheimer's disease 
when given in mice TgMHu2ME199K (exhibit typical 
pathological features of human CJD, Creutzfeldt Jacob 
disease, and of general neurodegeneration) and postponed 
the worsening of the disease in already sick animals. 
Analysis of brain samples revealed that the treatment 
reduced lipid oxidation and neuronal loss, indicating a 
neuroprotective effect 
Mizrahi et al., 
2014 
Israel 
Punica granatum 
L. (Lythraceae) 
Juice of the pomegranate 
fruits (6.5–7.5 mL of fluid 
per day) administered in 
their drinking water for 
two weeks 
Pomegranate juice exhibited neuroprotective effects in a 
rat model of rotenone that induces Parkinson's Disease. 
Oral administration juice of the pomegranate fruits did not 
mitigate or prevent experimental Parkinson's disease, but 
instead increased nigrostriatal terminal depletion, DA 
neuron loss, the inflammatory response and caspase 
activation, thereby heightening neurodegeneration. 
Observed increased nitrotyrosine levels, inducible nitric 
oxide synthase, and activated caspase-3 expression in 
nigral DA neurons is consistent with potential pro-oxidant 
activity of Pomegranate juice 
Tapias et al., 
2014 
USA 
Ruta graveolens 
L. (Rutaceae) 
Aqueous extract of leaves 
(0,01, 0,1, 1 and 10 
mg/mL) for 24, 48 and 72 
hours 
Extract induced cell death in glioblastoma lines (U87MG, 
C6 and U138), through the activation of the pathways by 
ERK1/2 and AKT. Interestingly, the rutin compound, 
isolated from the aqueous extract, does not induce cell 
death, suggesting that rutin alone is not responsible for the 
neuroprotective effects 
Gentile et al., 
2015 
Italy 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Compound 6-shogaol (1, 
5 and 10 μM) and doses 
of 5 mg/kg and 20 mg/kg 
once per day for 3 days in 
model in mice 
6-shogaol suppressed the activation of LPS-induced 
microglia in neuronal-glia cortical primary culture and 
showed neuroprotective effects in an in vivo 
neuroinflammatory model, acting on transient global 
ischemia through inhibition of microglia. It has been shown 
Ha et al., 2012 
Republic of Korea 
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to be an effective therapeutic agent for the treatment of 
neurodegenerative diseases by inhibiting the production of 
PGE2, IL-1β, TNF-α, p38 MAPK and NF-κB 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Aqueous extract of the 
rhizomes (0.1 mL/kg bw) 
was injected into the 
Baihui point for a period 
of 14 days after the 
occlusion of MCAO 
Extract co-administered to pharmacopuncture improves 
cognitive function and decreases oxidative stress after 
cerebral ischemia induced by occlusion of the MCAO in 
mice. Animals submitted to ginger treatment with 
pharmacopuncture presented increased levels of CAT and 
GPX, both cerebral cortex and hippocampus 
Jittiwat & 
Wattanathorn, 
2012 
Thailand 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Aqueous extract of the 
rhizomes 
Extract showed protective properties against Fe2+-induced 
lipid peroxidation in rat brain homogenates in vitro. The 
extract caused a significant decrease in the MDA contents 
of the brain of mice in a dose-dependent manner. The 
oxidative stress in the brain could be potentially 
managed/prevented by dietary intake of ginger 
Oboh et al., 
2012a 
Nigeria 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Aqueous extract of ginger 
rhizomes (100 μL) 
Extract exerted anti-Alzheimer properties in the rat brain in 
in vitro models. The extract inhibited the activity of AchE, 
sodium nitroprusside (SNP) and quinoline (QA) induced by 
lipid peroxidation, which can be attributed to the presence 
of phytochemicals such as flavonoids, alkaloids, tannins 
and terpenoids 
Oboh et al., 
2012b 
Nigeria 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Fresh ginger ethanolic 
extract (0.125–0.5 
mg/mL) and compounds 
8-gingerol, 
10-gingerol, 6-shogaol 
(5–20 μM) for 20 h of 
treatment 
Compounds inhibited the production of nitric oxide, IL-1β, 
IL-6 and TNF-α as well as their mRNA levels in LPS-
activated BV2 microglia. Blocking NF-κB activation was the 
underlying mechanism responsible for inhibiting the 
proinflammatory gene expression. Fresh ginger extract 
exhibited a significant anti-neuroinflammatory capacity, 
which was largely owing to 10-gingerol 
Ho et al., 2013 
Taiwan 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Hydro-alcoholic extract of 
fresh ginger rhizome (200 
or 300 mg/kg bw, every 
other day) for 30 days by 
i.p. injection 
Extract modulated the expression of IL-27 (is expressed by 
a variety of immune and non-immune 
cells, such as T cells, monocytes, dendritic cells, mast cells, 
hepatocytes, endothelial cells, neurons, B cells and NK 
cells) (up-regulated) and IL-33 (reported that IL-33 levels 
were elevated in the periphery and of the central nervous 
system of multiple sclerosis patients, implicating that IL-33 
may participate in the pathogenesis of multiple sclerosis) 
(down-regulated) in the spinal cord of mice in an 
experimental autoimmune encephalomyelitis (EAE) model 
Jafarzadeh et al., 
2014 
Iran 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Capsulets of powder of 
ginger rhizome (250 mg) 
only one 
capsulet upon headache 
onset 
Capsule administered in a randomized, double-blind 
clinical trial with 100 patients who had acute migraine was 
shown to be effective in the treatment of migraine attacks, 
with effect comparable to the drug sumatriptan. Capsule 
administration had a lower incidence of side effects than 
the drug 
Maghbooli et al., 
2014 
Iran 
Zingiber 
officinale Roscoe 
(Zingiberaceae) 
Compound 6-gingerol (25 
μM) trated for 24 h 
6-gingerol induced cell death of meningioma (IOMM-Lee 
and CH157MN cells) by apoptosis with phosphorylation of 
glycogen synthase kinase 3β (GSK3β) and inhibition of the 
Wnt5/β-catenin pathway. Apoptosis may be associated to 
Das et al., 2015 
USA 
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downregulation of tetraspanin protein (TSPAN12), survival 
proteins (Bcl-XL and Mcl-1), and overexpression apoptotic 
factors (Bax and caspase-3) 
 
From the selected articles in the two 
databases (Figure Nº 2), more than a third of the 
publications occurred in 2012 (34.92%). Curcuma 
longa L. (turmeric) was the medicinal plant with the 
highest number of published data totalizing 30 
studies (47,62% of all selected articles). 
  
 
 
 
 
 
 
 
Figure Nº 2 
Number of publications with neuroprotective potential distributed between 2010 and 2016, between 
RENISUS and C. Longa plants, plant with the largest amount of research. 
 
Out of the 63 articles, only three studies were 
developed by Brazilian institutions (Jaques et al., 
2012; Zanotto-Filho et al., 2012; Collaço et al., 
2012). We would have expected an increase in 
Brazilian scientific research after the creation of 
RENISUS, although that was not the case here. In 
terms of the 71 medicinal herbs of RENISUS, only 
12 plant species were reported within the scope of 
our review. Out of 12 plants with neuroprotective 
potential, two species, Glycine max L. (soy) and 
Mentha piperita L. (pepper mint), is currently 
available at SUS as phytotherapy. In addition, 
Mikania laevigata Sch.Bip. ex Baker (guaco) and 
Passiflora incarnata L. (passion fruit) are 
representative Brazilian plants.  
It is worthy to highlight that this systematic 
review evaluated so only a period of scientific 
production after the creation of RENISUS. 
Nevertheless, it is noteworthy that before and after 
that period numerous plant species have been 
scientifically proven for their neuroprotective 
potential including Panax ginseng C.A. Mey. 
(Chinese ginseng) (Van Kampen et al., 2014), 
Ginkgo biloba L. (ginkgo) (Saleem et al., 2008), 
Salvia officinalis L. (sage) (Eidi et al., 2006), 
Hypericum perforatum L. (St John’s wort) (Silva et 
al., 2004), Morus alba (white mulberry) (Kang et al., 
2006) and Bacopa monnieri L. (Brahmi) (Calabrese 
et al., 2008).  
 
DISCUSSION 
The present systematic review identified 63 reports 
on the effects of 12 medicinal herbs listed in 
RENISUS on neuroprotective potential. 
Neuroprotective properties are defined here as the 
ability to counteract and attenuate mechanisms that 
Marmitt et al.  Medicinal plants with neuroprotective potential 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/98 
 
may contribute to the pathogenesis and progression 
of neurodegenerative disorders. The pooled data 
revealed that the identification and characterization of 
new phytochemicals extracted from medicinal plants 
are vital for the development of new drugs for the 
treatment of neurological diseases such as the 
neurodegenerative ones. The potential of plants is 
justified by their importance in the most different 
medical applications. In addition, several plants 
traditionally used that were not the object of our 
study may also offer a great field for research to 
proving the efficacy and safety of their administration 
(Bolson et al., 2015; Adebayo et al., 2015). 
One of the most active compounds studied 
was curcumin, which is a polyphenol antioxidant of 
low molecular weight. It was first extracted from C. 
longa rhizomes thousands of years ago by Asians 
(Srivastava et al., 1985). Curcumin is one of the 
active phytochemicals found in high concentration in 
species of Zingiberaceae family and it has an 
exceptional safety profile and a number of pleiotropic 
actions with potential neuroprotective efficacy that 
can be achieved at submicromolar level (Chin et al., 
2013). All these facts corroborate with the number of 
studies on turmeric and ginger found in this review.  
As demographics move towards an aging 
population, neurological pathologies become one of 
the main challenges to the modern health care 
system. Therefore, the zeal directed by public health 
agencies for the use of medicinal plants has increased 
substantially. Since 1978, the World Health 
Organization (WHO) has been funding significant 
public investment in projects related to medicinal 
plants. Consequently, an increase in public interest in 
natural therapies can be seen in developing and 
developed countries resulting in growing acceptance 
of herbal medicines by health professionals and the 
population in general (Calvo & Cavero, 2015). 
Despite the abundance of Brazilian flora, the 
therapeutic profile of innumerous plants has not been 
properly explored (Oliveira et al., 2013; Martins et 
al., 2016). Seeking to enhance the knowledge of 
existing natural products in the country, since 2012, 
Brazil’s Ministry of Health launches funds focused 
on projects and research on medicinal plants. Since 
the creation of the fund, 66 projects in the country 
were awarded with budgets that totalize US$ 7 
million (Brazil, 2015). In this context, in order to 
guide and encourage professionals to prescribe plants 
and herbal medicines, ANVISA published in June 
2016, the Herbal Memento, which gathers detailed 
information on numerous RENISUS plants, 
containing data on contraindications, precautions for 
use, adverse effects, drug interactions, routes of 
administration and dosage (Brazil, 2016). 
 
CONCLUSION 
In conclusion, the outcomes of this systematic review 
have disclosed the neuroprotective potential of 12 
selected plant species of RENISUS. Data from 
preclinical studies showed that medicinal herbs might 
have potential benefit for the management of 
neurodegenerative diseases. In addition, the above-
mentioned beneficial properties of RENISUS plants 
contribute substantially to the medicinal knowledge 
of potentially important species, and this review can 
be used as a guide to new researches in the 
neurological field. 
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